Ledger.Open graph →
SEC Form D · Amendment · filed September 15, 2020

Gilgamesh Pharmaceuticals, Inc

Offering
—
Sold
$735K
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
New York, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Jonathan Sporn · New York, NYExec · DirectorDalibor Sames · New York, NYDirectorAndrew Kruegel · New York, NYDirectorGautam Shah · Cedar Park, TXDirectorJulie B. Sanders · Dallas, TXDirectorEdward Harycki · Bryn Mawr, PAExec · DirectorKent Gordon · Salt Lake City, UTDirectorJames T. Farrell · San Francisco, CADirectorGaurav Sahni · Short Hills, X1Exec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗